TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr | ₹13,653 Cr | ₹13,577 Cr |
What is the latest Total Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹14,505 Cr |
Mar2023 | ₹14,468 Cr |
Mar2022 | ₹12,606 Cr |
Mar2021 | ₹13,653 Cr |
Mar2020 | ₹13,577 Cr |
How is Total Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹14,505 Cr | 0.26 | |
Mar2023 | ₹14,468 Cr | 14.77 | |
Mar2022 | ₹12,606 Cr | -7.67 | |
Mar2021 | ₹13,653 Cr | 0.56 | |
Mar2020 | ₹13,577 Cr | - |
Compare Total Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,189.8 Cr | -1% | -0.5% | 13.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
MANKIND PHARMA | ₹97,164.6 Cr | -1.4% | -7.7% | 5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -1% |
-0.5% |
13.2% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses